Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

Not Applicable

Completed

• Conditions: Prostate Disease; Prostate Obstruction; Prostate Hypertrophy; Prostatic Neoplasms
• Interventions: Drug: Single dose tamsulosin 0.4mg; Drug: Double dose tamsulosin 0.4mg

• Registration Number: NCT05834270
• Lead Sponsor: Menoufia University

Brief Summary

Single dose versus double dose tamsulosin in Management of Moderate and severe lower urinary tract symptoms due to benign prostatic hyperplasia

Detailed Description

Not available

Study Timeline

• Study Start: 2022-05-01
• Primary Completion: 2022-12-01
• Study Completion: 2022-12-01
• Status Verified: 2023-04
• Study First Submitted: 2023-04-17
• Study First Submitted QC: 2023-04-17
• Last Update Submitted: 2023-04-17
• Study First Posted: 2023-04-28
• Last Update Posted: 2023-04-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

• age more than 50 years
• moderate to severe lower urinary tract symptoms

Exclusion Criteria

• prostatic cancer
• urethral stricture
• prostate surgery
• Neurogenic bladder

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Single dose tamsulosin 0.4mg	Single dose tamsulosin 0.4mg	Single dose tamsulosin 0.4mg
Double dose tamsulosin 0.4mg	Double dose tamsulosin 0.4mg	Double dose tamsulosin 0.4mg

Primary Outcome Measures

Name	Time	Method
Change in the lower urinary tract symptoms	3 months	Assessed by the improvement in the internal prostatic symptoms score (IPSS)

Trial Locations

Locations (1)

Faculty of Medicine; 🇪🇬 Shibīn Al Kawm, Menofia, Egypt